Citius Pharmaceuticals, Inc. (CTXR) Stock Analysis & Investment Frameworks
Citius Pharmaceuticals, Inc. (CTXR) stock analysis on Invetso. Review Citius Pharmaceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Citius Pharmaceuticals, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Citius Pharmaceuticals, Inc. Key Financial Metrics
- Market Cap: $14.96M
- Revenue: $N/A
- ROE: -67.15%
- ROIC: -67.62%
- Dividend Yield: N/A
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Citius Pharmaceuticals, Inc. Investment Frameworks
Invetso analyzes Citius Pharmaceuticals, Inc. (CTXR) across the following frameworks:
- Citius Pharmaceuticals, Inc. 10Y Growth Potential
- Citius Pharmaceuticals, Inc. Scenario Analysis
- Citius Pharmaceuticals, Inc. Risks & Opportunities
- Citius Pharmaceuticals, Inc. Economic Moat
- Citius Pharmaceuticals, Inc. Business Model
- Citius Pharmaceuticals, Inc. Management
- Citius Pharmaceuticals, Inc. SWOT Analysis
- Citius Pharmaceuticals, Inc. Porter's 5 Forces
- Citius Pharmaceuticals, Inc. PESTLE Analysis
- Citius Pharmaceuticals, Inc. ESG Analysis